维普期刊资源整合服务平台（V6.5）

211篇 您的检索式：作者名="Gralow"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	Paclitaxel plus Bevacizumab versus Paclitaxcel alone for metastatic breast cancer显示文摘	Miller K Wang M Gralow J	2007	N Engl J Med2007，357，26：	1
2	Clinical cancer advances 2008: Major research advances in cancer treatment, prevention, and screening-a report from the American Society of Clinical Oncology 显示文摘	Winer E Gralow J Diller L	2009	Journal of clinical oncology2009，27，：	1
3	NCCN Task Force Report:Bone Health in Cancer Care显示文摘	Gralow JR Biermann JS Farooki A	2009	J Natl Compr Canc Netw2009，7，3：	1
4	Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer显示文摘	Miller K Wang M Gralow J	2007	N Engl J Med2007，357，26：	1
5	Preoperative therapy in invasive breast cancer:pathologic assessment and systemic therapy issues in operable disease显示文摘	Gralow JR Burstein H J Wood W	2008	J Clin Oncol2008，26，5：	1
6	Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjurant chemotherapy 显示文摘	Mankoff DA Dunnwald LK Gralow JR	2003	J Nucl Med2003，44，11：	1
7	Changes in blood flow and metabolism in locally advancde breast eancer treated with neoadjuvant chemotherapy显示文摘	Mankoff DA Dunnwakd LK Gralow JR	2003	J Nucl Med2003，44，11：	1
8	Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant them otherapy 显示文摘	Mankoff DA Dunnwakd LK Gralow JR et el	2003	J Nucl Med2003，44，：	1
9	Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel- refractory metastatic breast cancer显示文摘	Livingston R B Ellis G K Gralow J R	1997	J Clin Oncol1997，15，4：	1
10	Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease显示文摘	Gralow JR BurStein HJ Wood W	2008	J Clin Oncol2008，26，5：	1
11	NCCN Task ForceReport : Bone Health In Cancer Care 显示文摘	Gralow JR Biermann JS Farooki A	2013	J Natl Compr CaneNetw2013，11，3：	1
12	Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer 显示文摘	Miller K Wang M Gralow J	2007	New Engl J Med2007，357，26：	1
13	Optimizing the treatment of metastatic breast cancer 显示文摘	Gralow J R	2005	Breast Cancer Res Treat2005，89，1：	1
14	Clinical Cancer Advances 2007: Major research advances in canc- er treatment, prevention, and screening: A report from the American society of clinical oncology 显示文摘	Gralow J Ozols R F Bajor IN D F	2007	J Clin On- col2007，26，2：	1
15	Optimising the dose of capecit- abine in metastatic breast cancer: confused, elarified or con- firmed? 显示文摘	Zielinski C Gralow J Martin M	2010	Ann Oneol2010，2，1：	1
16	Paclitaxel plus bev- acizumab versus paclitaxel alone for metastatic breast cancer显示文摘	Miller K Wang M Gralow J	2007	N Engl J Med2007，357，26：	1
17	Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer显示文摘	Miller K Wang M Gralow J	2007	N Engl J Med2007，357，26：	1
18	Peptide-based,but not whole protein,vaccines elicit immunity to Her-2/neu,oncogenic self-protein显示文摘	Disis ML Gralow JR Bernhard H	1996	J Immunol1996，156，9：	1
19	Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies显示文摘	Coleman RE Body JJ Gralow JR	2008	Cancer Treat Rev2008，34，1：	1
20	Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer显示文摘	Miller K Wang M Gralow J	2007	New Eng J Med2007，357，：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示